GlaxoSmithKline Pakistan Limited (PSX: GLAXO)

GlaxoSmithKline Pakistan Balance Sheet

Financials in millions PKR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,693	3,611	4,755	7,085	5,605	2,347
Short-Term Investments	-	-	-	1,633	450.62	342.86
Cash & Short-Term Investments	6,693	3,611	4,755	8,719	6,055	2,690
Cash Growth	75.02%	-24.06%	-45.47%	43.98%	125.11%	-21.64%
Accounts Receivable	623.73	1,028	1,585	1,316	1,204	1,127
Other Receivables	9,103	7,506	5,582	1,669	1,043	1,148
Receivables	10,958	8,587	7,217	3,043	2,299	2,334
Inventory	16,046	11,794	9,726	6,696	5,938	6,276
Prepaid Expenses	-	190.75	123	7.21	112.44	137.86
Other Current Assets	84.95	1,158	1,682	503.93	644.79	1,144
Total Current Assets	33,783	25,341	23,503	18,969	15,049	12,582
Property, Plant & Equipment	12,377	11,701	10,997	10,408	9,936	9,480
Goodwill	955.74	955.74	955.74	955.74	955.74	955.74
Other Intangible Assets	-	-	-	36	36	86
Other Long-Term Assets	50.15	50.15	27.52	22.01	22.01	22.01
Total Assets	47,257	38,131	35,542	30,455	26,072	23,229
Accounts Payable	8,377	1,616	560.52	652.17	659.75	709.77
Accrued Expenses	6,264	5,404	4,098	3,776	3,497	3,226
Short-Term Debt	-	572.93	284.14	235.75	334.67	-
Current Portion of Leases	23.92	35.94	16.5	20.89	7.78	8.87
Current Income Taxes Payable	832.89	68.69	936.81	1,116	-	-
Current Unearned Revenue	2,231	2,432	2,368	1,051	1,126	784.8
Other Current Liabilities	2,325	4,436	4,645	1,479	1,754	1,445
Total Current Liabilities	20,055	14,565	12,909	8,330	7,379	6,175
Long-Term Leases	144.09	116.04	45.42	32.71	31.56	42.56
Long-Term Deferred Tax Liabilities	1,114	1,181	957	806.63	674.97	645.96
Total Liabilities	22,000	16,455	14,489	9,469	8,594	7,092
Common Stock	3,185	3,185	3,185	3,185	3,185	3,185
Retained Earnings	20,946	17,364	16,742	16,675	13,167	11,826
Comprehensive Income & Other	1,127	1,127	1,127	1,127	1,127	1,127
Shareholders' Equity	25,257	21,676	21,053	20,987	17,478	16,137
Total Liabilities & Equity	47,257	38,131	35,542	30,455	26,072	23,229
Total Debt	168.01	724.9	346.07	289.36	374.01	51.43
Net Cash (Debt)	6,525	2,886	4,408	8,429	5,681	2,638
Net Cash Growth	71.78%	-34.54%	-47.70%	48.37%	115.32%	-23.14%
Net Cash Per Share	20.49	9.06	13.84	26.47	17.84	8.28
Filing Date Shares Outstanding	318.53	318.47	318.47	318.47	318.47	318.47
Total Common Shares Outstanding	318.53	318.47	318.47	318.47	318.47	318.47
Working Capital	13,728	10,776	10,595	10,639	7,671	6,407
Book Value Per Share	79.29	68.06	66.11	65.90	54.88	50.67
Tangible Book Value	24,301	20,720	20,097	19,995	16,487	15,096
Tangible Book Value Per Share	76.29	65.06	63.11	62.78	51.77	47.40
Land	-	316.41	316.41	316.41	331.56	331.17
Buildings	-	3,080	3,001	2,928	2,883	2,895
Machinery	-	13,856	12,773	12,119	11,387	10,887
Construction In Progress	-	1,295	1,236	1,178	1,029	599.31

Source: S&P Capital IQ. Standard template. Financial Sources.